Royalty Pharma plc (FRA:RPD)
Germany · Delayed Price · Currency is EUR 31.04
+0.05 (0.16%)
At close: Aug 15, 2025, 10:00 PM CET
Royalty Pharma Company Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes.
The company was founded in 1996 and is based in New York, New York.
Royalty Pharma plc
| Country | United Kingdom |
| Founded | 1996 |
| Industry | Pharmaceutical Preparations |
| CEO | Pablo Legorreta |
Contact Details
Address: 110 East 59th Street New York, 10022 United States | |
| Phone | 212 883 0200 |
| Website | royaltypharma.com |
Stock Details
| Ticker Symbol | RPD |
| Exchange | Frankfurt Stock Exchange |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Pablo Legorreta | Chief Executive Officer |
| Terrance Coyne | Chief Financial Officer |
| George Grofik | Head of Investor Relations |